Log in to save to my catalogue

Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b h...

Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b h...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2694762942

Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection

About this item

Full title

Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection

Publisher

Tokyo: Springer Japan

Journal title

Journal of gastroenterology, 2019-01, Vol.54 (1), p.78-86

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Background
The prevalence of hepatitis C virus (HCV) infection in hemodialysis patients is high and results in a poor prognosis. Thus, safer and more effective treatment regimens are required. In this prospective multicenter study, we investigated the efficacy and safety of the novel HCV-NS5A-inhibitor, elbasvir, and protease inhibitor, grazopre...

Alternative Titles

Full title

Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2694762942

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2694762942

Other Identifiers

ISSN

0944-1174

E-ISSN

1435-5922

DOI

10.1007/s00535-018-1495-6

How to access this item